These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 22180105)

  • 1. Synthesizing single-case studies: a Monte Carlo examination of a three-level meta-analytic model.
    Owens CM; Ferron JM
    Behav Res Methods; 2012 Sep; 44(3):795-805. PubMed ID: 22180105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The consequences of modeling autocorrelation when synthesizing single-case studies using a three-level model.
    Petit-Bois M; Baek EK; Van den Noortgate W; Beretvas SN; Ferron JM
    Behav Res Methods; 2016 Jun; 48(2):803-12. PubMed ID: 26463724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making treatment effect inferences from multiple-baseline data: the utility of multilevel modeling approaches.
    Ferron JM; Bell BA; Hess MR; Rendina-Gobioff G; Hibbard ST
    Behav Res Methods; 2009 May; 41(2):372-84. PubMed ID: 19363177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating individual treatment effects from multiple-baseline data: a Monte Carlo study of multilevel-modeling approaches.
    Ferron JM; Farmer JL; Owens CM
    Behav Res Methods; 2010 Nov; 42(4):930-43. PubMed ID: 21139160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confidence intervals for the overall effect size in random-effects meta-analysis.
    Sánchez-Meca J; Marín-Martínez F
    Psychol Methods; 2008 Mar; 13(1):31-48. PubMed ID: 18331152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?
    Huedo-Medina TB; Sánchez-Meca J; Marín-Martínez F; Botella J
    Psychol Methods; 2006 Jun; 11(2):193-206. PubMed ID: 16784338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When can group level clustering be ignored? Multilevel models versus single-level models with sparse data.
    Clarke P
    J Epidemiol Community Health; 2008 Aug; 62(8):752-8. PubMed ID: 18621963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varying coefficient meta-analytic methods for alpha reliability.
    Bonett DG
    Psychol Methods; 2010 Dec; 15(4):368-85. PubMed ID: 20853952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis tests for population heterogeneity in meta-analysis.
    Viechtbauer W
    Br J Math Stat Psychol; 2007 May; 60(Pt 1):29-60. PubMed ID: 17535578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis.
    Rücker G; Schwarzer G; Carpenter JR; Binder H; Schumacher M
    Biostatistics; 2011 Jan; 12(1):122-42. PubMed ID: 20656692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing meta-regression methods for examining moderator relationships with dependent effect sizes: A Monte Carlo simulation.
    López-López JA; Van den Noortgate W; Tanner-Smith EE; Wilson SJ; Lipsey MW
    Res Synth Methods; 2017 Dec; 8(4):435-450. PubMed ID: 28556477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulation sample sizes for Monte Carlo partial EVPI calculations.
    Oakley JE; Brennan A; Tappenden P; Chilcott J
    J Health Econ; 2010 May; 29(3):468-77. PubMed ID: 20378190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of multiple outcomes: a multilevel approach.
    Van den Noortgate W; López-López JA; Marín-Martínez F; Sánchez-Meca J
    Behav Res Methods; 2015 Dec; 47(4):1274-1294. PubMed ID: 25361866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesizer 1.0: a varying-coefficient meta-analytic tool.
    Krizan Z
    Behav Res Methods; 2010 Aug; 42(3):863-70. PubMed ID: 20805608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confidence intervals for random effects meta-analysis and robustness to publication bias.
    Henmi M; Copas JB
    Stat Med; 2010 Dec; 29(29):2969-83. PubMed ID: 20963748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian bivariate meta-analysis of diagnostic test studies using integrated nested Laplace approximations.
    Paul M; Riebler A; Bachmann LM; Rue H; Held L
    Stat Med; 2010 May; 29(12):1325-39. PubMed ID: 20101670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confidence intervals for the amount of heterogeneity in meta-analysis.
    Viechtbauer W
    Stat Med; 2007 Jan; 26(1):37-52. PubMed ID: 16463355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of omitting the interaction between crossed factors in cross-classified random effects modelling.
    Shi Y; Leite W; Algina J
    Br J Math Stat Psychol; 2010 Feb; 63(Pt 1):1-15. PubMed ID: 19243680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
    Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
    Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.